From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA panel considers 1st drug for chronic fatigue syndrome

from HealthDay News

A U.S. Food and Drug Administration advisory committee will meet to consider approval of the first drug to treat chronic fatigue syndrome. The experts will discuss the risks and benefits associated with the intravenous drug rintatolimod. The drug's maker, Hemispherx Biopharma, failed to win the FDA's OK in 2009 because of concerns about study methodology. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063